Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (CH:NOV)
:NOV
Total Valuation
Novo Nordisk has a market cap or net worth of CHF202.07B. The enterprise value is CHF2.04T.
Market CapCHF202.07B
Enterprise ValueCHF2.04T
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders0.04%
Owned by Institutions<0.01%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 38.99%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)38.99%
Return on Capital Employed (ROCE)0.52
Revenue Per Employee3.75M
Profits Per Employee1.30M
Employee Count77,406
Asset Turnover0.62
Inventory Turnover1.09
Valuation Ratios
The current PE Ratio of Novo Nordisk is ―. Novo Nordisk’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value19.38
Price to FCF0.00
Price to Operating Cash Flow11.46
PEG Ratio―
Income Statement
In the last 12 months, Novo Nordisk had revenue of 290.40B and earned 100.99B in profits. Earnings per share was 22.67.
Revenue290.40B
Gross Profit245.88B
Operating Income128.34B
Pretax Income127.19B
Net Income100.99B
EBITDA137.38B
Earnings Per Share (EPS)22.67
Cash Flow
In the last 12 months, operating cash flow was 123.78B and capital expenditures -61.05B, giving a free cash flow of 62.74B billion.
Operating Cash Flow123.78B
Free Cash Flow62.74B
Free Cash Flow per Share18.51
Dividends & Yields
Novo Nordisk pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change0.00%
50-Day Moving Average173.42
200-Day Moving Average173.42
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Novo Nordisk upcoming earnings date is Feb 4, 2026, Before Open (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateFeb 4, 2026
Ex-Dividend Date―
Financial Position
Novo Nordisk as a current ratio of 0.74, with Debt / Equity ratio of 59.06%
Current Ratio0.74
Quick Ratio0.55
Debt to Market Cap0.03
Net Debt to EBITDA0.63
Interest Coverage Ratio66.53
Taxes
In the past 12 months, Novo Nordisk has paid 26.20B in taxes.
Income Tax26.20B
Effective Tax Rate0.21
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 20.87, with an EV/FCF ratio of 41.16.
EV to Sales9.87
EV to EBITDA20.87
EV to Free Cash Flow41.16
EV to Operating Cash Flow23.70
Balance Sheet
Novo Nordisk has CHF32.58B in cash and marketable securities with CHF118.72B in debt, giving a net cash position of -CHF68.63B billion.
Cash & Marketable SecuritiesCHF32.58B
Total DebtCHF118.72B
Net Cash-CHF68.63B
Net Cash Per Share-CHF20.24
Tangible Book Value Per ShareCHF7.27
Margins
Gross margin is 83.95%, with operating margin of 44.19%, and net profit margin of 34.78%.
Gross Margin83.95%
Operating Margin44.19%
Pretax Margin43.80%
Net Profit Margin34.78%
EBITDA Margin47.31%
EBIT Margin44.36%
Analyst Forecast
The average price target for Novo Nordisk is CHF47.89, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF47.89
Price Target Upside-72.39% Downside
Analyst ConsensusModerate Buy
Analyst Count12
Revenue Growth Forecast―
EPS Growth Forecast―